Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Deucravacitinib helped a man regrow hair significantly.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The gene NM_026333 slows down aging by affecting the NCX1 pathway and could be targeted for anti-aging treatments.

Targeting the AhR pathway may help treat alopecia areata.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.